サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1679378

脳磁図の市場規模、シェア、動向分析レポート：用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

Magnetoencephalography Market Size, Share & Trends Analysis Report By Application (Clinical, Research), By End Use (Hospitals, Imaging Centers), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 180 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
脳磁図の市場規模、シェア、動向分析レポート：用途別、最終用途別、地域別、セグメント別予測、2025年～2030年
出版日: 2025年02月24日
発行: Grand View Research
ページ情報: 英文 180 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

脳磁図市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の脳磁図市場規模は2030年までに4億3,260万米ドルに達し、2025～2030年のCAGRは5.9%で拡大すると推定されています。

新製品の発売頻度の増加、てんかんや脳卒中などの神経疾患の発生率の上昇が市場成長の主要促進要因です。また、高齢者は神経変性疾患に罹患しやすいため、高齢者の増加も市場成長を促進すると予想されます。世界保健機関（WHO）によると、神経疾患は世界全体の死因の12％を占める主要な死因です。

MEG技術は、脳内に生じる微弱な磁場を検出し、それを用いて脳の機能性を定量化し、脳の活動をマッピングします。臨床の場では、MEGは多くの固有の応用を記載しています。スキャンは、記録の受動的性質により、安全で静かな雰囲気の中で行うことができ、患者の同伴者がシールドされた領域内に立ち会うことさえ可能です。

全頭システムの導入やコンピュータ技術の開発など、技術開発が市場開拓に貢献する可能性が高く、MEGは過去20年間で大きく進化しました。正確で先進的定位が要求される場合はいつでも、MEGは現在、選択される画像モダリティです。さらに、脳磁図（MEG）は、研究者が大規模な脳活動のつながりや力学を研究するために使用される貴重なツールです。

市場の著名な競合企業は、製品ポートフォリオを拡大し、製造能力を強化するために、中堅・中小企業を買収しています。例えば、ノッティンガム大学はケント州のMagnetic Shields Limited（MSL）と提携し、世界最先端の機能的ウェアラブル脳スキャナーを市場に送り出すスピンアウト新会社、Cerca Magnetics Limitedを開発しました。これは、スキャン中に人々が自由に動き回れるように設計されています。

脳磁図市場レポートハイライト

  • 用途別では、臨床セグメントが2024年に最大の収益シェアを占め、さらに予測期間中のCAGRは6.1%と最速の成長が見込まれています。
  • 臨床セグメントはさらに、認知症、自閉症、統合失調症、多発性硬化症、脳卒中、てんかん、その他に細分化され、てんかんサブセグメントは、世界の有病率の増加により、最大の市場シェアを占めています。
  • 最終用途別では、新興諸国における病院数の増加と医療サービスプロバイダー間の競争激化により、病院セグメントが2024年に最大のシェアを占めました。
  • イメージングセンター部門は、その利便性、近接性、患者や保険者にとっての低コストのため、予測期間中に最も速い成長率を経験すると予想されています。
  • 2024年の脳磁図市場は、北米が33.9%の最大収益シェアを占めました。同地域には主要メーカーが存在し、研究開発投資の増加、政府の資金援助やイニシアチブの増加が予測期間中の市場成長を後押しすると見られています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 脳磁図市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/付随市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 脳磁図市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 脳磁図市場：用途別、推定・動向分析

  • セグメントダッシュボード
  • 世界の脳磁図、用途市場変動分析
  • 世界の脳磁図市場規模と動向分析、用途別、2018～2030年
  • 臨床
    • 痴呆
    • 自閉症
    • 統合失調症
    • 多発性硬化症
    • 脳卒中
    • てんかん
    • その他
  • 研究

第5章 脳磁図市場：最終用途別、推定・動向分析

  • セグメントダッシュボード
  • 世界の脳磁図、最終用途市場変動分析
  • 世界の脳磁図市場規模と動向分析、最終用途別、2018～2030年
  • 病院
  • 画像センター
  • 学術研究機関

第6章 脳磁図市場：地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 世界地域市場スナップショット
  • 市場規模、予測動向分析、2018～2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 規制枠組み/償還構造
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 規制枠組み/償還構造
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • 規制枠組み/償還構造
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 規制枠組み/償還構造
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • 主要企業の市場シェア分析、2024年
  • 企業ポジション分析
  • 企業分類（新興企業、イノベーター、リーダー）
  • 企業プロファイル
    • Compumedics Limited
    • MEGIN
    • Ricoh
    • CTF MEG NEURO INNOVATIONS, INC.
    • FieldLine Inc.
    • Cerca Magnetics Limited
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 4 Global magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 5 North America magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 6 North America magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 7 North America magnetoencephalography market by Country, 2018 - 2030 (USD Million)
  • Table 8 U.S. magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 9 U.S. magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 10 Canada magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 11 Canada magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 12 Mexico magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 13 Mexico magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 14 Europe magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 15 Europe magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 16 Europe magnetoencephalography market by Country, 2018 - 2030 (USD Million)
  • Table 17 UK magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 18 UK magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 19 Germany magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 20 Germany magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 21 France magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 22 France magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 23 Italy magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 24 Italy magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 25 Spain magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 26 Spain magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 27 Denmark magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 28 Denmark magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 29 Sweden magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 30 Sweden magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 31 Norway magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 32 Norway magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific magnetoencephalography market by Country, 2018 - 2030 (USD Million)
  • Table 36 China magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 37 China magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 38 Japan magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 39 Japan magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 40 India magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 41 India magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 42 Australia magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 43 Australia magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 44 Thailand magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 45 Thailand magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 46 South Korea magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 47 South Korea magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 48 Latin America magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 49 Latin America magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 50 Latin America magnetoencephalography market by Country, 2018 - 2030 (USD Million)
  • Table 51 Brazil magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 52 Brazil magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 53 Argentina magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 54 Argentina magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa magnetoencephalography market by Country, 2018 - 2030 (USD Million)
  • Table 58 South Africa magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 59 South Africa magnetoencephalography market by Product, 2018 - 2030 (USD Million)
  • Table 60 South Africa magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia magnetoencephalography market by Product, 2018 - 2030 (USD Million)
  • Table 63 Saudi Arabia magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 64 UAE magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 65 UAE magnetoencephalography market by Product, 2018 - 2030 (USD Million)
  • Table 66 UAE magnetoencephalography market by End Use, 2018 - 2030 (USD Million)
  • Table 67 Kuwait magnetoencephalography market by Application, 2018 - 2030 (USD Million)
  • Table 68 Kuwait magnetoencephalography market by Product, 2018 - 2030 (USD Million)
  • Table 69 Kuwait magnetoencephalography market by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Magnetoencephalography market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Magnetoencephalography market: Application outlook and key takeaways
  • Fig. 12 Magnetoencephalography market: Application movement analysis
  • Fig. 13 Clinical market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Dementia market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Autism market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Schizophrenia market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Multiple Sclerosis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Stroke market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Epilepsy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Research market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Magnetoencephalography market: End Use outlook and key takeaways
  • Fig. 23 Magnetoencephalography market: End Use movement analysis
  • Fig. 24 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Imaging centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Academic and research institutes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Magnetoencephalography market: Regional key takeaways (USD Million)
  • Fig. 28 Magnetoencephalography market regional outlook, 2023 & 2030, USD Million
  • Fig. 29 North America magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Canada magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Mexico magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Europe magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 UK magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Germany magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 France magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Spain magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Italy magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Sweden magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Norway magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 China magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Japan magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 India magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 South Korea magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Australia magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Thailand magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Latin America magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Brazil magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Argentina magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Middle East and Africa magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 UAE magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Kuwait magnetoencephalography market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 List of key emerging companies/technology disruptors/innovators
目次
Product Code: GVR-4-68039-618-0

Magnetoencephalography Market Growth & Trends:

The global magnetoencephalography market size is estimated to reach USD 432.6 million by 2030, expanding at a CAGR of 5.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growing frequency of new product launches and the rise in the incidence of neurological disorders such as epilepsy, and stroke are key drivers to market growth. In addition, the growing geriatric population is also expected to drive market growth since they are more prone to neurodegenerative diseases. According to the World Health Organization, neurological disorders are a leading cause of death, accounting for 12% of all deaths worldwide.

MEG technologies detect the weak magnetic fields created in the brain and use them to quantify brain functionality and map brain activity. In a clinical setting, MEG provides a number of inherent applications. Scans can be performed in a safe and silent atmosphere due to the passive nature of the recordings, which even allows a patient's companion to be present within the shielded area.

Technological developments are likely to contribute to market expansion, such as the introduction of whole-head systems and developments in computer technology, MEG has evolved significantly in the last two decades. Whenever a precise and high degree of localization is required, MEG is now the imaging modality of choice. Furthermore, magnetoencephalography (MEG), is an invaluable tool that is used by researchers to study the connections and dynamics of large-scale brain activity.

The market's prominent competitors are acquiring medium and small-sized businesses in order to expand their product portfolio and enhance their manufacturing capacity. For instance, the University of Nottingham has partnered with Magnetic Shields Limited (MSL) of Kent to develop Cerca Magnetics Limited, a new spin-out company that will deliver the world's most advanced functional wearable brain scanner to market. It is designed to let people move around freely while being scanned.

Magnetoencephalography Market Report Highlights:

  • Based on application, the clinical segment accounted for the largest revenue share in 2024 and is further expected to grow at the fastest CAGR of 6.1% over the forecast period.
  • The clinical segment is further sub-segmented into dementia, autism, schizophrenia, multiple sclerosis, stroke, epilepsy, and others, in which the epilepsy sub-segment held the largest market share owing to its increasing prevalence worldwide
  • In terms of end use, the hospital segment held the largest share in 2024, owing to the increasing number of hospitals in developing countries and growing competition among healthcare service providers
  • The imaging center segment is expected to experience the fastest growth rate during the forecast period due to its convenience, proximity, and lower costs to patients and insurers
  • North America dominated the magnetoencephalography market with the largest revenue share of 33.9% in 2024. The presence of key manufacturers in the region, increase in R&D investments, and rise in government funding & initiatives are expected to boost market growth over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Magnetoencephalography Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increase in prevalence of neurological disorders
      • 3.2.1.2. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of MEG
      • 3.2.2.2. Presence of alternative diagnostic devices
  • 3.3. Magnetoencephalography Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Magnetoencephalography Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Magnetoencephalography Application Market Movement Analysis
  • 4.3. Global Magnetoencephalography Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 4.4. Clinical
    • 4.4.1. Clinical market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Dementia
      • 4.4.2.1. Dementia diagnosis market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Autism
      • 4.4.3.1. Autism market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Schizophrenia
      • 4.4.4.1. Schizophrenia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.5. Multiple Sclerosis
      • 4.4.5.1. Multiple sclerosis market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.6. Stroke
      • 4.4.6.1. Stroke market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.7. Epilepsy
      • 4.4.7.1. Epilepsy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.8. Others
      • 4.4.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Research
    • 4.5.1. Research market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Magnetoencephalography Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Magnetoencephalography End Use Market Movement Analysis
  • 5.3. Global Magnetoencephalography Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Imaging Centers
    • 5.5.1. Imaging centers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Academic and Research Institutes
    • 5.6.1. Academic and research institutes market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Magnetoencephalography Market: Regional Estimates & Trend Analysis By Application, End Use

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Competitive scenario
      • 6.5.1.3. Regulatory framework/ reimbursement structure
      • 6.5.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework/ reimbursement structure
      • 6.5.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Competitive scenario
      • 6.5.3.3. Regulatory framework/ reimbursement structure
      • 6.5.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. Regulatory framework/ reimbursement structure
    • 6.6.2. UK
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework/ reimbursement structure
      • 6.6.2.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.6.3. Germany
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive scenario
      • 6.6.3.3. Regulatory framework/ reimbursement structure
      • 6.6.3.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.6.4. France
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Competitive scenario
      • 6.6.4.3. Regulatory framework/ reimbursement structure
      • 6.6.4.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.6.5. Italy
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Competitive scenario
      • 6.6.5.3. Regulatory framework/ reimbursement structure
      • 6.6.5.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.6.6. Spain
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Competitive scenario
      • 6.6.6.3. Regulatory framework/ reimbursement structure
      • 6.6.6.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.6.7. Norway
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Competitive scenario
      • 6.6.7.3. Regulatory framework/ reimbursement structure
      • 6.6.7.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.6.8. Sweden
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Competitive scenario
      • 6.6.8.3. Regulatory framework/ reimbursement structure
      • 6.6.8.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.6.9. Denmark
      • 6.6.9.1. Key country dynamics
      • 6.6.9.2. Competitive scenario
      • 6.6.9.3. Regulatory framework/ reimbursement structure
      • 6.6.9.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Regulatory framework/ reimbursement structure
    • 6.7.2. Japan
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework/ reimbursement structure
      • 6.7.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.7.3. China
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework/ reimbursement structure
      • 6.7.3.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.7.4. India
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework/ reimbursement structure
      • 6.7.4.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.7.5. Australia
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive scenario
      • 6.7.5.3. Regulatory framework/ reimbursement structure
      • 6.7.5.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.7.6. South Korea
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Competitive scenario
      • 6.7.6.3. Regulatory framework/ reimbursement structure
      • 6.7.6.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.7.7. Thailand
      • 6.7.7.1. Key country dynamics
      • 6.7.7.2. Competitive scenario
      • 6.7.7.3. Regulatory framework/ reimbursement structure
      • 6.7.7.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Regulatory framework/ reimbursement structure
    • 6.8.2. Brazil
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Competitive scenario
      • 6.8.2.3. Regulatory framework/ reimbursement structure
      • 6.8.2.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Competitive scenario
      • 6.8.3.3. Regulatory framework/ reimbursement structure
      • 6.8.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. Regulatory framework/ reimbursement structure
    • 6.9.2. South Africa
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Competitive scenario
      • 6.9.2.3. Regulatory framework/ reimbursement structure
      • 6.9.2.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.9.3. Saudi Arabia
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Competitive scenario
      • 6.9.3.3. Regulatory framework/ reimbursement structure
      • 6.9.3.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.9.4. UAE
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Competitive scenario
      • 6.9.4.3. Regulatory framework/ reimbursement structure
      • 6.9.4.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.9.5. Kuwait
      • 6.9.5.1. Key country dynamics
      • 6.9.5.2. Competitive scenario
      • 6.9.5.3. Regulatory framework/ reimbursement structure
      • 6.9.5.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Key company market share analysis, 2024
  • 7.4. Company Position Analysis
  • 7.5. Company Categorization (Emerging Players, Innovators and Leaders
  • 7.6. Company Profiles
    • 7.6.1. Compumedics Limited
      • 7.6.1.1. Company overview
      • 7.6.1.2. Financial performance
      • 7.6.1.3. Product benchmarking
      • 7.6.1.4. Strategic initiatives
    • 7.6.2. MEGIN
      • 7.6.2.1. Company overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Product benchmarking
      • 7.6.2.4. Strategic initiatives
    • 7.6.3. Ricoh
      • 7.6.3.1. Company overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Product benchmarking
      • 7.6.3.4. Strategic initiatives
    • 7.6.4. CTF MEG NEURO INNOVATIONS, INC.
      • 7.6.4.1. Company overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Product benchmarking
      • 7.6.4.4. Strategic initiatives
    • 7.6.5. FieldLine Inc.
      • 7.6.5.1. Company overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Product benchmarking
      • 7.6.5.4. Strategic initiatives
    • 7.6.6. Cerca Magnetics Limited
      • 7.6.6.1. Company overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Product benchmarking
      • 7.6.6.4. Strategic initiatives